60 Degrees Pharmaceuticals, Inc. (SXTP)

1.08 0.00 (0.00%) USD  |  NASDAQ  |  Aug 25, 15:23
More

60 Degrees Pharmaceuticals EPS Estimates for Current Fiscal Year

EPS Estimates for Current Fiscal Year Chart

View EPS Estimates for Current Fiscal Year for SXTP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Estimates for Current Fiscal Year Chart
Start Trial

Historical EPS Estimates for Current Fiscal Year Data

View and export this data back to 2024. Start Trial.
Date Value
May 22, 2026 --
April 09, 2026 --
November 27, 2025 --
September 03, 2025 --
June 02, 2025 --
April 07, 2025 --
Date Value
November 23, 2024 --
August 20, 2024 --
May 21, 2024 --
April 08, 2024 --
February 26, 2024 --

Earnings Per Share Estimates Definition

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for Current Fiscal Year Range, Past 5 Years

View EPS Estimates for Current Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Estimates for Current Fiscal Year Benchmarks

View EPS Estimates for Current Fiscal Year Benchmarks
Start Trial
Harrow, Inc. Upgrade
ANI Pharmaceuticals, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade
Veru, Inc. Upgrade
Johnson & Johnson Upgrade

EPS Estimates for Current Fiscal Year Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Next Fiscal Year Upgrade